Formerly doing business as ThermalVision, Avedro, Inc., is a medical device company advancing the science and technology of corneal cross-linking and refractive correction.. The firm offers a non-invasive refractive correction procedure that reshapes the cornea. The company also develops systems for performing corneal cross-linking for the treatment of keratoconus and post-Lasik ectasia; and solutions for the correction of myopia and other refractive disorders. In addition, it offers accessories, such as targeting stages and applicators, as well as bioinsulators for the dielectrically controlled transmission of the microwave energy. Further, the company involves in developing the science of thermo-biomechanics for therapeutic medical applications. Avedro recently completed its US?based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the United States, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo-biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo-biomechanics platform and is a non-invasive, incision-less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the corneas biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.
